From Fibromuscular Dysplasia to Arterial Dissection and Back
American Journal of Hypertension · 2023
DOI: 10.1093/ajh/hpad056 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Hypertension, 2023. Verfasst von Justine Huart und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, University of Liège Hospital (ULiège CHU), University of Liège, Liège, Belgium. Hauptthemen laut MEDLINE: Fibromuscular Dysplasia, Aortic Dissection, Coronary Vessel Anomalies, Vascular Diseases. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: UCLouvain, Belgium.
Abstract (Originalsprache)
Fibromuscular dysplasia (FMD) is an idiopathic and systemic non-inflammatory and non-atherosclerotic arterial disease. Fifteen to 25% of patients with FMD present with arterial dissection in at least one arterial bed. Conversely, a substantial number of patients with renal, carotid, and visceral dissection have underlying FMD. Also, while few patients with FMD develop coronary artery dissection, lesions suggestive of multifocal FMD have been reported in 30–80% of patients with spontaneous coronary artery dissection (SCAD), and the relation between these two entities remains controversial. The frequent association of FMD with arterial dissection, both in coronary and extra-coronary arteries raises a number of practical and theoretical questions: (i) Are FMD and arterial dissections two different facets of the same disease or distinct though related entities? (ii) Is SCAD just a manifestation of coronary FMD or a different disease? (iii) What is the risk and which are predictive factors of developing arterial dissection in a patient with FMD? (iv) What proportion of patients who experienced an arterial dissection have underlying FMD, and does this finding influence the risk of subsequent arterial complications? In this review we will address these different questions using fragmentary, mostly cross-sectional evidence derived from large registries and studies from Europe and the United States, as well as arguments derived from demographics, clinical presentation, imaging, and when available histology and genetics. From there we will derive practical consequences for nosology, screening and follow-up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Nephrology, University of Liège Hospital (ULiège CHU), University of Liège, Liège, Belgium.
- Groupe Interdisciplinaire de Génoprotéomique Appliquée (GIGA), Division of Cardiovascular Sciences, University of Liège, Liège, Belgium.
- Department of Internal Medicine, Rheumatology, Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium.
- Neurology Unit, Stroke Unit, AUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
- Neuroradiology Unit, AUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
- Department of Cardiovascular Sciences, University of Leicester and NIHR Leicester Biomedical Research Centre, Leicester, UK.
ORCID-Profile: Alexandre Persu
Förderung
- UCLouvain, Belgium
Zitieren
APA
Huart, J., Stoenoiu, M. S., Zedde, M., Pascarella, R., Adlam, D., & Persu, A. (2023). From Fibromuscular Dysplasia to Arterial Dissection and Back. American Journal of Hypertension. https://doi.org/10.1093/ajh/hpad056
Vancouver
Huart J, Stoenoiu MS, Zedde M, Pascarella R, Adlam D, Persu A. From Fibromuscular Dysplasia to Arterial Dissection and Back. American Journal of Hypertension. 2023. doi:10.1093/ajh/hpad056
BibTeX
@article{Huart2023,
author = {Huart, Justine and Stoenoiu, Maria S and Zedde, Marialuisa and Pascarella, Rosario and Adlam, David and Persu, Alexandre},
title = {From Fibromuscular Dysplasia to Arterial Dissection and Back},
journal = {American Journal of Hypertension},
year = {2023},
doi = {10.1093/ajh/hpad056}
}
EUVIMED